Personalized cell therapy shows promise for advanced cervical cancer
Disease control
Terminated
This study tested a new treatment called LN-145 for people with cervical cancer that has come back or spread. The treatment uses a patient's own immune cells (tumor-infiltrating lymphocytes) that are grown in a lab and then given back to fight the cancer. The study aimed to see i…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC